Fizazi, et al. ARAMIS: Efficacy and safety of darolutamide in nonmetastatic castration-resistant prostate cancer (nmCRPC). ASCO-GU 2019, abstract 140.
Craniale radiotherapie bij acute lymfatische leukemie leidt tot hersenschade later
apr 2017 | Leukemie, Radiotherapie